Belgian Communications Stock News

ENXTBR:CPINV
ENXTBR:CPINVHealth Care REITs

Care Property Invest (ENXTBR:CPINV) Q1 Revenue Performance Tests Bearish Growth Narratives

Care Property Invest (ENXTBR:CPINV) has opened 2026 with Q1 revenue of €20.8m and net income of €17.9m, setting the tone for how investors will assess the latest numbers against a stock price of €12.90. The company has seen quarterly revenue move from €18.6m in Q1 2025 to €20.8m in Q1 2026. Trailing 12 month revenue sits at €77.4m alongside trailing net income of €59.0m, giving a clear picture of the recent income profile before factoring in dividends or valuation. With margins recently...
ENXTBR:BEKB
ENXTBR:BEKBMetals and Mining

A Look At Bekaert’s (ENXTBR:BEKB) Valuation After Dividend Increase Leadership Change And Q1 Update

Dividend decision and leadership changes set the tone for NV Bekaert NV Bekaert (ENXTBR:BEKB) has just wrapped up an eventful May, with shareholders approving a gross dividend of €1.95 per share alongside director reappointments, while the company confirmed Q1 2026 sales in line with expectations. See our latest analysis for NV Bekaert. Following the annual meeting, Q1 sales update, recent acquisitions in Thailand and China, and the appointment of a new CEO, the stock’s 1-day share price...
ENXTBR:PROX
ENXTBR:PROXTelecom

Will Weaker Q1 2026 Earnings Momentum Change Proximus' (ENXTBR:PROX) Investment Narrative?

Proximus PLC has reported past first-quarter 2026 results showing sales of €1,510 million and revenue of €1,525 million, with net income of €124 million and basic earnings per share from continuing operations of €0.38, all lower than the same period a year earlier. This broad-based decline across sales, revenue and earnings measures raises questions about how effectively Proximus’s existing efficiency programs and investment plans are offsetting current pressures on its business. We’ll now...
ENXTBR:VGP
ENXTBR:VGPReal Estate

Assessing VGP (ENXTBR:VGP) Valuation After Recent Share Price Weakness

Recent share performance and business context VGP (ENXTBR:VGP) has drawn investor attention after the stock declined 10.2% over the past day, extending falls of 5.6% over the past week and 11.3% over the past month. Those moves come as the €2.21b logistics and semi industrial real estate company, headquartered in Antwerp, continues to generate revenue of €191.99m and net income of €290.44m. This performance is partly supported by its renewable energy activities. See our latest analysis for...
ENXTBR:SOF
ENXTBR:SOFDiversified Financial

Assessing Sofina Société Anonyme (ENXTBR:SOF) Valuation After Recent Share Price Weakness

Short term moves put Sofina Société Anonyme (ENXTBR:SOF) under the spotlight Sofina Société Anonyme (ENXTBR:SOF) has drawn attention after its stock fell 1.1% in the latest session and is now down about 2.3% over the past month and 12.5% over the past 3 months. With a market value of about €7.7b and a last close of €218.40, the company offers exposure to a broad mix of private equity and venture capital holdings spanning digital transformation, healthcare, education, consumer sectors and...
ENXTBR:VIO
ENXTBR:VIOMetals and Mining

Assessing Viohalco (ENXTBR:VIO) Valuation After Investor Interest In Its Diversified Metals And Cables Operations

Viohalco (ENXTBR:VIO) drew attention after its stock climbed 13.55% in after-hours trading on EURONEXT on 7 May, as investors focused on its aluminium, copper, cables, and steel operations. See our latest analysis for Viohalco. That after hours jump adds to strong recent momentum, with a 7 day share price return of 16.45% and a 30 day share price return of 23.60%. The 1 year total shareholder return of 218.26% and 5 year total shareholder return of 288.09% underline how sentiment has shifted...
ENXTBR:KBCA
ENXTBR:KBCABanks

Assessing KBC Ancora (ENXTBR:KBCA) Valuation After Recent Mixed Share Price Performance

Recent returns and what they might mean for investors KBC Ancora (ENXTBR:KBCA) has quietly posted mixed share price moves, with a 0.6% decline over the past day, a 2.2% gain over the past week, and around 4.5% over the past month. For longer term holders, the stock shows a modest gain of about 0.3% over the past 3 months, alongside a year to date return of roughly 5.4% and a 1 year total return close to 38.3%. See our latest analysis for KBC Ancora. With the share price at €79.4, KBC Ancora...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Argenx Leadership Shift And Vyvgart Milestones Reshape Autoimmune Growth Story

argenx (ENXTBR:ARGX) appointed Karen Massey as CEO, and co founder Tim Van Hauwermeiren moved to Chairperson. The company reported strong Q1 results, with accelerating VYVGART sales highlighted as a key driver. An FDA decision on a potential Vyvgart label expansion in seronegative generalized myasthenia gravis is expected soon. argenx focuses on antibody based therapies for autoimmune diseases, with VYVGART already a central product in its portfolio. For investors watching the immunology...
ENXTBR:SYENS
ENXTBR:SYENSChemicals

Syensqo Share Cancellation Reshapes Ownership As Valuation Gap Persists

Syensqo cancelled a significant number of shares it had repurchased as part of its ongoing buyback program. The move changes the total number of outstanding shares and voting rights for ENXTBR:SYENS. The action forms part of a broader capital management approach that affects how ownership is distributed across shareholders. For investors watching ENXTBR:SYENS, the cancellation of repurchased shares directly alters the share count that sits behind the current €57.3 price. Recent performance...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Solvay (ENXTBR:SOLB) Q1 Profit Of €26 Million Tests Loss-Making Narrative

Solvay (ENXTBR:SOLB) opened 2026 with Q1 revenue of €1.1 billion and basic EPS of €0.25, alongside trailing twelve month revenue of €4.6 billion and a basic EPS loss of €0.24, setting a mixed backdrop for the latest results. Over recent quarters the company has seen revenue range between €1.1 billion and €1.3 billion per quarter, with basic EPS moving from €0.78 in Q1 2025 through several smaller profits and a loss of €0.90 in Q4 2025 before rebounding in Q1 2026, leaving investors focused on...
ENXTBR:ABI
ENXTBR:ABIBeverage

Anheuser-Busch InBev (ENXTBR:ABI) Margin Stability Supports Bullish Long Term Growth Narratives

Anheuser-Busch InBev (ENXTBR:ABI) opened 2026 with Q1 revenue of US$15.3b and basic EPS of US$1.30, setting a clear benchmark for how the rest of the year might shape up for the brewer’s top and bottom lines. The company has seen quarterly revenue move from US$13.6b in Q1 2025 to US$15.3b in Q1 2026, while basic EPS shifted from US$1.08 to US$1.30 over the same period. This gives you a clean read on how sales and per share earnings are tracking through the cycle. With that backdrop, the...
ENXTBR:COFB
ENXTBR:COFBHealth Care REITs

A Look At Cofinimmo (ENXTBR:COFB) Valuation After Q1 Earnings Reveal Higher Sales And Lower Net Income

Earnings snapshot and why it matters now Cofinimmo (ENXTBR:COFB) has just reported first quarter 2026 results, with sales of €87.31 million compared with €86.81 million a year earlier, while net income came in at €53.51 million versus €64.26 million. This mix of slightly higher sales and lower profitability is giving investors fresh numbers to reassess the stock, especially following the recent share price moves over the past month and over the past three months. See our latest analysis for...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

Is It Time To Reassess argenx (ENXTBR:ARGX) After Its Strong Multi Year Run?

Investors may be wondering whether argenx at €678.60 is offering fair value or carrying a premium, particularly after its strong long term share price record. The stock has returned 2.0% over the last 7 days, 4.9% over the last 30 days, a 6.2% decline year to date and 19.8% over the last year, with longer term returns of 86.7% over 3 years and 220.1% over 5 years. Recent coverage around argenx has focused on its position in the biotech sector and investor debate around how much future growth...
ENXTBR:XIOR
ENXTBR:XIORResidential REITs

A Look At Xior Student Housing (ENXTBR:XIOR) Valuation After Its Stronger First Quarter Results

Why Xior’s latest quarterly results matter for investors Xior Student Housing (ENXTBR:XIOR) has drawn fresh attention after reporting first quarter 2026 earnings, with sales of €48.67 million and net income of €48.6 million, compared with €43.88 million and €41.95 million a year earlier. See our latest analysis for Xior Student Housing. Despite the stronger first quarter figures, the share price is at €27.6, with a 1 day share price return of 0.91% but a 1 year total shareholder return of...
ENXTBR:UMI
ENXTBR:UMIChemicals

Umicore Leadership Shakeup Puts Digital Transformation And Execution In Focus

Umicore (ENXTBR:UMI) has appointed Lily Liu as Chief Financial Officer and Executive Vice President. The company is also creating a new Chief Digital & Transformation Officer role to focus on digitalization and operational excellence. These leadership changes reflect a shift in how Umicore organizes its executive team and oversees transformation initiatives. For investors watching ENXTBR:UMI, the leadership reshuffle comes with the stock at €17.18 and a mixed return profile. The share price...
ENXTBR:ABI
ENXTBR:ABIBeverage

Dividend Hike and Board Refresh Could Be A Game Changer For Anheuser-Busch InBev (ENXTBR:ABI)

At its 29 April 2026 shareholder meeting, Anheuser-Busch InBev approved a €1.15 gross total dividend for 2025 and refreshed its board, appointing Fabrizio Freda and Miguel Patricio as directors alongside new Restricted Share Directors. Coupled with a planned US$600.00 million investment in U.S. manufacturing and workforce training, these moves highlight AB InBev’s focus on strengthening operations and supporting shareholder returns. Next, we’ll examine how AB InBev’s newly approved...
ENXTBR:AGS
ENXTBR:AGSInsurance

Ageas Tightens Grip On Belgium While Eyeing India Growth And Valuation

ageas (ENXTBR:AGS) has completed the acquisition of the remaining stake in AG Insurance, consolidating full ownership of its Belgian insurance business. The company has issued new and treasury shares to BNP Paribas Cardif, increasing its outstanding share capital and reshaping its shareholder base. ageas is accelerating expansion in India, aiming for a top 10 position through acquisitions and deeper bancassurance partnerships. For investors watching ENXTBR:AGS, these moves come as the share...